← Leaderboards
Melissa Schwenk
Giner Life Sciences, Inc.
$222,005
Attributed
$222,005
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$222,005 · 1
By mechanism
R43$222,005 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Antibiotics”
- Urs Ochsner · Crestone, Inc.$36,950,837
- Ryan Cirz · Revagenix, Inc.$35,410,554
- Daniel Pevear · Venatorx Pharmaceuticals, Inc.$24,789,028
- Bruce Blough · Research Triangle Institute$19,637,160
- Thomas Dick · Rbhs-New Jersey Medical School$15,241,285
- Steven Armen Boyd · Venatorx Pharmaceuticals, Inc.$13,685,544
Research focus
AntibioticsAreaAtmosphereBaseBostonCardiovascular SystemCaringCell Membrane PermeabilityChronic WoundDensityDesignDevice DesignsDevicesDimensionsDosageDropsElectronicsEnvironmentFailureFda ApprovedFeasibility StudiesFundingGasesAnatomy